Ligilactobacillus salivarius CRL1328 (DSM 24441) (formerly Lactobacillus salivarius)

Single strain
Single strain
On this page

Gynecology

Urogenital health

Under worldwide exclusive license from the CEntro de REferencia para LActobacilos, Argentina

Functionality

Supports vaginal health

Supports a healthy vaginal microbiota

Inhibits pathogenic Candida, Gonorrhea, E. faecalis, and E. faecium [in vitro]

Available Formats

Single strain

Blend

Finished dosage form

Scientific Support
In vitro studies

a) Ocana V. et al. Characterization of a bacteriocin like substance produced by a vaginal Lactobacillus salivarius strain. Applied and Environmental Microbiology, 1999; 65(12):5631-5635.  DOI: 10.1128/AEM.65.12.5631-5635.1999

b) Ocana V. et al. Surface characteristics of Lactobacilli isolated from human vagina. J. Gen. Appl. Microbiol., 1999; 45:203-212. DOI: 10.2323/jgam.45.203

c) Tomas MSJ. et al. Influence of pH, temperature and culture media on the growth and bacteriocin production by vaginal Lactobacillus salivarius CRL 1328. Journal of Applied Microbiology, 2002; 93: 714-724. DOI: 10.1046/j.1365-2672.2002.01753.x

d) Gillor O. et al. The dual role of bacteriocins as anti- and probiotics. Appl Microbiol Biotechnol. 2008 December; 81(4): 591–606. DOI: 10.1007/s00253-008-1726-5

e) Dover S.E. et al. Natural antimicrobials and their role in vaginal health: a short review. Int J Probiotics Prebiotics. 2008 ; 3(4): 219–230.

f) Juárez Tomás M.S. et al. Viability of vaginal probiotic Lactobacilli during refrigerated and frozen storage. Anaerobe, Vol 10, Issue 1, February 2004, 1-5. DOI: 10.1016/j.anaerobe.2004.01.002

g) Zàrate G. and Nader-Macias ME. Influence of probiotic vaginal Lactobacilli on in vitro adhesion of urogenital pathogens to vaginal epithelial cells. Letters in Applied Microbiology ISSN 0266-8254. DOI: 10.1111/j.1472-765X.2006.01934.x

h) Ocana V and Nader-Macias ME. Adhesion of Lactobacillus Vaginal Strains with Probiotic Properties to Vaginal Epithelial Cells, 2011, Biocell 25(3):265-273.

i) Ocana V and Nader-Macias ME. Vaginal Lactobacilli: self and coaggregating ability, British Journal of Biomedical Science 2002, 59(4). DOI: 10.1080/09674845.2002.11783657

j) Tomas MSJ et al. Characterization of potentially probiotic vaginal Lactobacilli isolated from Argentinean women. British Journal of Biomedical Science 2005 62(4). DOI: 10.1080/09674845.2005.11732706

k) Vera Pingitore E. et al. Characterization of salivaricin CRL 1328, a twopeptide bacteriocin produced by Lactobacillus salivarius CRL 1328 isolated from the human vagina. Res Microbiol. 2009;160(6):401-408. DOI: 10.1016/j.resmic.2009.06.009

l) Vera Pingitore E. et al. Influence of vitamins and osmolites on growth and bacteriocin production by Lactobacillus salivarius CRL 1328 in a chemically defined medium. Can J Microbiol. 2009;55(3):304-310. DOI: 10.1139/w08-092

m) Vera Pingitore E. et al. Design of novel urogenital pharmabiotic formulations containing Lactobacilli, salivaricin CRL 1328 and non- microbial compounds with different functionalities. Drug Dev Ind Pharm. 2015;41(6):942-952. DOI: 10.3109/03639045.2014.917092

n) Vera Pingitore E. et al. Effect of lyophilization and storage temperature on the activity of salivaricin CRL 1328, a potential bioactive ingredient of a urogenital probiotic product. J Gen Appl Microbiol. 2012;58(2):71-81. DOI: 10.2323/jgam.58.71

Associations